FPCG
HZNP

Fort Pitt Capital Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Fort Pitt Capital Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,200
Closed -$88K – 375
2020
Q4 		$88K Buy
+1,200
New +$89.2K ﹤0.01% 163

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Fort Pitt Capital Group's HZNP Position: Q1 2021 in Review

Fort Pitt Capital Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2021, closing a stake of 1,200 shares — an estimated $88K sold.

Fort Pitt Capital Group first reported a position in HZNP in Q4 2020 and held it in 1 quarter. The position peaked at $88K in Q4 2020. 517 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.

  • Fort Pitt Capital Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Fort Pitt Capital Group sold 1,200 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $88K.
  • Fort Pitt Capital Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 1 quarter.
  • Fort Pitt Capital Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $88K in Q4 2020.
  • 517 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.

Based on Fort Pitt Capital Group's 13F filing for Q1 2021, filed 16 Apr 2021.